Nakahira, Hiroko
Takeuchi, Yoji
Shimamoto, Yusaku
Ishiguro, Shingo
Yunokizaki, Hiroshi
Ezoe, Yasumasa
Fujisawa, Fumie
Ishihara, Ryu
Takayama, Tetsuji
Yoshida, Teruhiko
Mutoh, Michihiro
Ishikawa, Hideki
Funding for this research was provided by:
Japan Agency for Medical Research and Development (22ck0106556h0003, 22ck0106556h0003, 22ck0106556h0003, 22ck0106556h0003)
Article History
Received: 28 December 2022
Accepted: 3 October 2023
First Online: 27 November 2023
Declarations
:
: This study was approved by the Institutional Review Board of Osaka International Cancer Institute (2018–18229 and 2019–19006). Informed consent was obtained in the form of an opt-out on the institutional websites. The study was performed in accordance with the guidelines of the World Medical Association’s Declaration of Helsinki. All authors consent to publish this manuscript.
: Not applicable.
: Yoji Takeuchi has received honoraria for lectures from Olympus, Boston Scientific Japan, Daiichi-Sankyo, Miyarisan Pharmaceutical, Asuka Pharmaceutical, AstraZeneca, EA Pharma, Zeria Pharmaceutical, Fujifilm, Kaneka Medix, and Kyorin Pharmaceutical. The other authors declare that they have no competing interests.